| Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis DB Sacdalan, JA Lucero, DL Sacdalan OncoTargets and therapy, 955-965, 2018 | 285 | 2018 |
| Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials C Axfors, P Janiaud, AM Schmitt, J van’t Hooft, ER Smith, NA Haber, ... BMC infectious diseases 21, 1-23, 2021 | 63 | 2021 |
| The association between inflammation and immunosuppression: implications for ICI biomarker development DB Sacdalan, JA Lucero OncoTargets and therapy, 2053-2064, 2021 | 14 | 2021 |
| Physicians’ perceptions on the role of telemedicine in cancer care during and post-COVID-19 Pandemic EM Cruz-Lim, MJ Mendoza, P Dumlao III, JA Lucero, B Yap, CV Garcia Acta Medica Philippina 55 (2), 2021 | 9 | 2021 |
| Revisiting a lower starting dose of alectinib in ALK-positive non-small cell lung cancer DB Sacdalan, JA Lucero Cancer Treatment and Research Communications 27, 100319, 2021 | 9 | 2021 |
| Public-private partnership options toward achieving universal health coverage in the Philippine setting EP Banzon, JA Lucero, BL Ho, ME Puyat, EJ Quibod, PA Factor PIDS Discussion Paper Series, 2014 | 7 | 2014 |
| What will keep me coming back to the clinic: Factors identified by Filipino colorectal cancer patients seen at a national academic referral center DB Sacdalan, JA Lucero, FI Ting, DL Sacdalan Journal of Patient Experience 7 (4), 460-463, 2020 | 4 | 2020 |
| FIP1L1-PDGFRA–Positive Hypereosinophilia Presenting with Bilateral Extracranial Carotid Artery Aneurysms KMC Moalong, JDB Diestro, AI Espiritu, JAC Lucero, JM Valencia, ... World Neurosurgery 139, 419-422, 2020 | 2 | 2020 |
| Evaluation of tuberculosis Infection control Strategies at the Philippine General Hospital RDD Agustin, JAC Lucero, RP Berba Acta Medica Philippina 52 (1), 2018 | 2 | 2018 |
| Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation J Lucero, M Alhumaid, I Novitzky-Basso, JM Capo-Chichi, T Stockley, ... Annals of Hematology 103 (4), 1187-1196, 2024 | 1 | 2024 |
| HIV screening among patients with newly diagnosed solid and hematologic malignancies in a tertiary hospital in the Philippines JB Poblete, ARM Villafuerte, MJL Mendoza, AFG Malundo, JAC Lucero, ... Acta Medica Philippina 58 (5), 2024 | 1 | 2024 |
| Therapeutic plasma exchange in thyroid storm refractory to conventional treatment HHC Chiu, JPD Sarsagat, HB Dominguez, JAC Lucero, ABC Uy, ... Acta Medica Philippina 56 (5), 2022 | 1 | 2022 |
| Longitudinally extensive transverse myelitis as a rare paraneoplastic presentation in chronic myelogenous leukemia JA Lucero, JA Balane, K Roberto, T Dumagay Current Problems in Cancer: Case Reports 3, 100062, 2021 | 1 | 2021 |
| 292P Shared decision-making at the cancer institute adult outpatient clinics of a tertiary hospital in the Philippines: A cross sectional study MJ Mendoza, EE Cua, LS Infante, JA Lucero, RA Imperio-Onglao, ... Annals of Oncology 31, S1355-S1356, 2020 | 1 | 2020 |
| Assessing the Feasibility of Public-Private Partnerships in Health in the Philippines EP Banzon, JA Lucero, BL Ho, ME Puyat, PA Factor, FJ Young PIDS Discussion Paper Series, 2014 | 1 | 2014 |
| Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol MA Perusini, C Andrews, AG Eshetu, V Gupta, D Maze, KWL Yee, ... Leukemia 38 (4), 912-913, 2024 | | 2024 |
| Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients with COVID-19: The Co-CLARITY Trial DTV Gauiran, TE Dumagay, MAC Ang, CC Dungog, FMM Climacosa, ... Acta Medica Philippina 58 (2), 2024 | | 2024 |
| Prognostic Role of Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia Patients with FMS3-like Tyrosine Kinase-3 Internal … JA Lucero, A Bankar, MB Davidson, G Richard-Carpentier, AD Schimmer, ... Blood 142, 1595, 2023 | | 2023 |
| Retrospective Study to Evaluate Probability of MR4 Maintenance Following Frontline Nilotinib Dose De-Escalation after MR4 Achievement in the Patients with Chronic Myeloid … E Al-Shaibani, MA Perusini, JA Lucero, G Gupta, M Chiu, F Gul, DDH Kim Blood 142, 6386, 2023 | | 2023 |
| New Pattern of Emerging Somatic Mutations in Optimal Responders Following Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients Evidenced from Mutational … G Gupta, M Chiu, E Al-Shaibani, MA Perusini, J Lucero, D Zackova, ... Blood 142, 4531, 2023 | | 2023 |
